Literature DB >> 22014740

Antipyretic, anti-inflammatory and analgesic properties of nilavembu kudineer choornam: a classical preparation used in the treatment of chikungunya fever.

K Anbarasu1, Kumar K T Manisenthil, S Ramachandran.   

Abstract

OBJECTIVE: To investigate the efficacy of ethanolic extract of nilavembu kudineer choornam (EENKC) in inflammation, pain and fever using animal models to support its actions.
METHODS: Acute toxicity study of EENKC was performed in mice to fix the effective dose. The antipyretic, anti-inflammatory and analgesic activity of EENKC was evaluated in brewer's yeast induced pyrexia in rats, carrageenan-induced inflammation in rats and acetic-acid induced writhing in mice model.
RESULTS: Acute toxicity revealed that EENKC didn't show death and toxic signs up to 2 000 mg/kg. In brewer's yeast induced pyrexia and carrageenan-induced inflammation EENKC at the doses of 200 and 400 mg/kg inhibited fever and inflammation significantly (P<0.01 and <0.05) compared to control animals. In mice, the number of writhing induced by acetic-acid was significantly (P<0.01) reduced after treatment with both the dose of EENKC than control animals. EENKC 200 mg/kg inhibits inflammation higher level in carrageenan-induced paw edema, but there is no significant difference when compared to indomethacin 10 mg/kg.
CONCLUSIONS: The present findings revealed that EENKC possesses antipyretic, anti-inflammatory and analgesic activity which supports nilavembu kudineer choornam efficacy in chikungunya fever.
Copyright © 2011 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014740     DOI: 10.1016/S1995-7645(11)60201-0

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  7 in total

1.  Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy.

Authors:  G Koushik Kumar; G Prasanna; T Marimuthu; N T Saraswathi
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

2.  Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial.

Authors:  Anurag Srivastava; Manickavasagam Rengaraju; Saurabh Srivastava; Vimal Narayanan; Vivek Gupta; Rashmi Upadhayay; Jitender Kumar; Sathiyarajeswaran Parameswaran
Journal:  Trials       Date:  2021-08-28       Impact factor: 2.728

3.  Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against Chikungunya virus infection.

Authors:  Jaspreet Jain; Somnath Pai; Sujatha Sunil
Journal:  Virusdisease       Date:  2018-01-25

4.  Pharmacognostical, phytochemical and pharmacological evaluation for the antipyretic effect of the seeds of Saraca asoca Roxb.

Authors:  S Sasmal; S Majumdar; M Gupta; A Mukherjee; P K Mukherjee
Journal:  Asian Pac J Trop Biomed       Date:  2012-10

5.  Extraction, Characterization, Antioxidant, and Immunostimulatory Activities of Polysaccharides from Hedyotis corymbosa.

Authors:  Li-Mei Lin; Su-Hui Xiong; Ling-Jia Zhao; Jie Tang; Zhi-Min Zhang; Ya-Mei Li; Tao Zheng; Bo-Hou Xia
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-14       Impact factor: 2.629

6.  Integrating medical doctors of modern and Indian system of medicine--Unique opportunity for India along the lines of China.

Authors:  Saravanan Subramanian
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

Review 7.  Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya.

Authors:  Anjali Soni; Khushhali M Pandey; Pratima Ray; B Jayaram
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.